A Canadian Survey of Cancer Patients’ Experiences

Ashbury, Fredrick D.; Findlay, Helen; Reynolds, Barbara; McKerracher, Krista

doi:10.1016/s0885-3924(98)00102-x

Cited by 219 publications

(165 citation statements)

References 17 publications

Supporting

Mentioning

134

Contrasting

Unclassified

Order By: Relevance

“…There have been some studies which have concentrated on information sources. Ashbury et al (1998) asked a group of 913 cancer patients about helpful sources of information. Nurses (61%), specialists (61%) and other cancer patients (60%) were reported by respondents to be helpful sources of information.…”

Section: Anxiety-provoking Issuesmentioning

confidence: 99%

Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study

et al. 2004

View full text Add to dashboard Cite

A postal questionnaire was sent to affluent and deprived women with breast cancer in order to compare psychosocial aspects of care with the purpose of understanding the balance of care and explaining why deprived women have poorer outcomes. Data were collected regarding reported sources of information, SF-36 scores and ongoing causes of anxiety. The results demonstrate that affluent women were more likely to have received information from their hospital specialist (94.8 vs 76.0%) and from a breast care nurse (70.1 vs 40.0%) than deprived women. They were also more likely to have received information from magazines (50.6 vs 33.0%), newspapers (45.5 vs 22.0%) and television news (45.5 vs 26.0%). Deprived women had poorer SF-36 scores than affluent women, and reported greater anxiety about money (12.2 vs 2.8%), other health problems (22.1 vs 8.2%) and family problems (17.5 vs 6.9%). Personal and professional support is clearly important for patients with breast cancer. Health professionals need to be aware of the greater psychological distress demonstrated by deprived women, even some years after diagnosis with breast cancer, and seek to address it. British Journal of Cancer (2004) There is a higher incidence of breast cancer in affluent women than in socioeconomically deprived women (Tomatis, 1990). However, several studies have shown deprived women to have poorer survival from breast cancer. Previous work carried out by the authors (Macleod et al, 2000a) confirmed earlier research (Carnon et al, 1994;Schrijvers et al, 1995) in showing no relationship between deprivation and pathological prognostic factors in women with early breast cancer. In addition, we have shown (Macleod et al, 2000b) that the NHS delivered health care equitably to women with breast cancer who lived in affluent and deprived areas. In particular, socioeconomic status did not affect breast surgery, radiotherapy or adjuvant treatments.The care of women with breast cancer is not, however, limited to surgical and oncological treatments but also includes provision of information and psychosocial care and support. Although breast cancer is largely treated in hospitals by specialist surgeons and oncologists (Gillis and Hole, 1996) women spend the majority of their time after diagnosis in the community. Our study has shown that there were greater numbers of consultations with general practitioners following diagnosis than before diagnosis for all women, but that the greatest number were for women living in deprived areas (Macleod et al, 2000b).The relationship between breast cancer outcomes and psychosocial factors is complex and several studies have shown a link between socioeconomic status and broader psychosocial issues. Social class has been shown to have an effect on psychiatric outcome at 12 months after mastectomy with women in lower social classes having the worst outcome (Dean, 1987). Other research has suggested that women with breast cancer from lower socioeconomic groups may be particularly receptive to interventions that will enhance the...

show abstract

Section: Anxiety-provoking Issuesmentioning

confidence: 99%

Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Улучшение показателей КЖ и увеличение периода вре-мени до ухудшения симптомов было продемонстрировано в рамках нескольких клинических рандомизированных исследований, изучающих эффективность и безопасность ингибиторов тирозинкиназы (ИТК) у больных НМРЛ с акти-вирующими мутациями в структуре гена рецептора эпи-дермального фактора роста (EGFR) [11,14,15,22]. Известно, что больные НМРЛ, опухоли которых имеют мутацию в структуре гена рецептора эпидермального фактора роста EGFR, являются высокочувствительными к первой линии терапии ингибиторами тирозинкиназы EGFR [17].…”

unclassified

“…В исследовании LUX-Lung 6 афатиниб сравнивали с комбинацией цисплатин + гемцитабин в азиатской попу-ляции больных с распространенным НМРЛ с наличием мутации EGFR [11,29].…”

unclassified

“…Результаты продольного анализа неизменно демонстри-ровали значительное негативное влияние прогрессиро-вания на КЖ (р < 0,0001) (рис. 5) [11].…”

unclassified

“…Разница в данных результатов ANCOVA между LUXLung 1 и LUX-Lung 3 может отражать тот факт, что кли-нически значимые изменения КЖ возможно труднее достичь у пациентов с интенсивной предшествующей терапией, как, например, тех, которые были включены в LUX-Lung 1. Положительные изменения в основных пока-зателях жизни в исследованиях, в рамках которых изу-чался афатиниб, были продемонстрированы, несмотря на достаточно высокую частоту предсказуемых нежела-тельных явлений, которые были управляемы и обратимы (класс-эффект ИТК) [11].…”

unclassified

See 2 more Smart Citations